Comparison between somatostatin analog injections

Creative Commons License

Gezer E., Demirhan Y., Selek A., Cantürk Z., Cetinarslan B., Sözen M., ...Daha Fazla

REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, cilt.68, sa.4, ss.514-518, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 68 Sayı: 4
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1590/1806-9282.20211224
  • Dergi Adı: REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Sayfa Sayıları: ss.514-518
  • Anahtar Kelimeler: Octreotide, Lanreotide, Injection site reaction, Drug-related side effects and adverse reactions, LANREOTIDE AUTOGEL, ACROMEGALIC PATIENTS, OCTREOTIDE-LAR, THERAPY, PATIENT, TOLERABILITY, FORMULATION, MANAGEMENT, CROSSOVER, EFFICACY
  • Kocaeli Üniversitesi Adresli: Evet

Özet

OBJECTIVE: Long-acting depot formulations of somatostatin analogs, i.e., octreotide and lanreotide, are the first-line medical therapies for patients with acromegaly to whom surgery/radiotherapy cannot be performed or who have inadequate response. In this study,we aimed to evaluate the short-term local and systemic adverse reactions developed after the somatostatin analogs injections in the patients with acromegaly, in order to compare the side effects of somatostatin analogs injections.